68-2

88/110

180Arai H, Suzuki T: Prenatal exposure to valproic acid is associated with altered neuro‑cognitive functions and neurogenesis in the dentate gyrus of male offspring rats. Brain Res, 2019; 1723: 146403 ＊ 18) Kawamura M, Sato S, Matsumoto G, Fukuda T, Shiba-Fukushima K, Noda S, Takanashi M, Mori N, Hattori N: Loss of nuclear REST/NRSF in aged-dopaminergic neurons in Parkinson’ disease patients. Neuroscience letters. 2019; 699: 59-63. 19) Cossu D, Yokoyama K, Sakanishi T, Momotani E, Hattori N: Adjuvant and antigenic proper‑ties of Mycobacterium avium susp. paratu‑berculosis on experimental autoimmune encephalomyelitis. Journal of Neuroimmu‑nology, 2019; 330: 174-177. 20) Cossu D, Yokoyama K, Hattori N, Sechi LA: From Sardinia to Japan: an update on the role of MAP in multiple sclerosis. Future Microbiology, 2019; 14: 643-646. 21) Tsukita Y, Okazaki T, Ebihara S, Komatsu R, Nihei M, Kobayashi M, Hirano T, Sugiura H, Tamada T, Tanaka N, Sato Y, Yagita H, Ichi‑nose M: Beneficial effects of sunitinib on immuno‑tumor microenvironment and therapy targeting death receptor 5. Oncoim‑munology, 2019; 8: e1543526. 22) Piao X, Miura R, Miyake S, Komazawa-Sakon S, Koike M, Shindo R, Tekeda J, Hasegawa A, Abe R, Nishiyama C, Mikami T, Yagita H, Uchiyama Y, Nakano H: Blockade of TNFR1- dependent and -independent cell death is crucial for normal epidermal differentiation. J. Allergy Clin. Immunol, 2019; 143: 213-228. 23) van Duijn J, Kritikou E, Benne N, T van der Heijden, GH van Puijvelde, Kroner MJ, Schaftenaar FH, Foks AC, Wezel A, Smeets H, Yagita H, Bot I, Jiskoot W, Kuiper J, Slutter B: CD8+ T-cells contribute to lesion stabiliza‑tion in advanced atherosclerosis by limiting macrophage content and CD4+ T-cell responses. Cardiovasc. Res, 2019; 115: 729-738. 24) Muraoka D, Seo N, Hayashi T, Tahara Y, Fujii K, Tawara I, MiyaharaY, Okamori K, Yagita H, Imoto S, Yamaguchi R, Komura M, Miyana S, Goto M, Sawada SI, Asai A, Ikeda H, Akiyoshi K, Harada N, Shiku H: Antigen delivery targeted to tumor-associated macro‑phages overcomes tumor immune resistance. J Clin Invest, 2019; 129: 1278-1294. 25) Gemta LF, Siska PJ, Nelson ME, Gao X, Liu X, Locasale JW, Yagita H, Slingluff Jr CL, Hoehn KL, Rathmell JC, Bullock TNJ: Impaired enolase 1 glycolytic activity restrains effector functions of tumor-infiltrating CD8+ T cells. Sci. Immunol, 2019; 4: eaap9520. 26) Nomura R, Kashimada K, Suzuki H, Zhao L, Hosokawa-Tsuji A, Yagita H, Takagi M, Kanai Y, Bowles J, Koopman P, Kanai-Azuma M, Morio T: Nr5a1 suppression during the fetal period optimizes ovarian development by fine-tuning of Notch signaling. J. Cell Sci, 2019; 132: jcs223768. 27) Hawk CS, Coelho C, Oliveira DSL, Paredes V, Albuquerque P, Bocca AL, Correa Dos Santos A, Rusakova V, Holemon H, Silva-Pareira I, Felipe MSS, Yagita H, Nicola AM, Casadevall A: Integrin b1 promotes the interaction of murine IgG3 with effector cells. J. Immunol, 2019; 202: 2782-2794. 28) Sakamoto T, Obara N, Nishiki H, Kato T, Luan CS, Fujimura R, Yagita H, Sakata- Yanagimoto M, Takahashi S, Chiba S: Notch signaling in Nestin-expressing cells in the bone marrow maintains erythropoiesis via macrophage integrity. Stem Cells, 2019; 37: 924-936. 29) Zhao P, Wang P, Dong S, Zhou Z, Cao Y, Yagita H, He X, Zheng SG, Fisher SJ, Fuji‑nami RS, Chen M: Depletion of PD-1-positive cells ameliorates autoimmune disease. Nat. Biomed. Eng, 2019; 3: 292-305. 30) Deng W, Yuan J, Cha J, Sun X, Bartos A, Yagita H, Hirota Y, Dey SK: Endothelial cells in the decidual bed are potential therapeutic targets for preterm birth prevention. Cell Rep, 2019; 27: 1755-1768. 31) Hamoudi D, Marcadet L, Piette AB, Yagita H, Bouredji Z, Argaw A, Frenette J: An anti-RANKL treatment reduces muscle inflamma‑tion and dysfunction and strengthens bone in dystrophic mice. Hum. Mol. Genet, 2019; 28: 3101-3112. 32) Camara A, Cordeiro OG, Alloush F, Sponsel J, Chypre M, Onder L, Asano K, Tanaka M, Yagita H, Ludewig B, Flacher V, Mueller CG: Lymph node mesenchymal and endothelial